Gabapentin in neuropathic pain syndromes: A randomised, double-blind, placebo-controlled trial

Pain

Volumn 99, Issue 3, 2002, Pages 557-566

  Serpell, M G ^a,b  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b UK and Republic of Ireland Participating Investigators ^*  (United Kingdom)

Author keywords

Antiepileptic; Neuralgia; Neurontin gabapentin; Neuropathic pain; Neuropathies; Quality of life patient outcomes

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; GABAPENTIN; MORPHINE; PLACEBO; VALPROIC ACID;

ABDOMINAL PAIN; ACCIDENT; ADULT; AGED; ALLODYNIA; ARTICLE; BURNING SENSATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG TOLERANCE; FEMALE; FLU LIKE SYNDROME; HEADACHE; HEALTH SURVEY; HUMAN; HYPERALGESIA; INFECTION; INJURY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROPATHIC PAIN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOM; SYNDROME; TITRIMETRY; TREATMENT OUTCOME; VERTIGO;

ACETIC ACIDS; ADULT; AGED; AGED, 80 AND OVER; AMINES; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PAIN; QUALITY OF LIFE; SYNDROME;

EID: 0036803061     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00255-5     Document Type: Article

References (32)

1. Attal N., Brasseur L., Parker F., Chauvin M., Bouhassira D. Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study. Eur Neurol. 40:1998;191-200.
2. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. J Am Med Assoc. 280:1998;1831-1836.
3. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 92:2001;147-157.
4. Boureau F., Doubrere J.F., Luu M. Study of verbal description in neuropathic pain. Pain. 42:1990;145-152.
5. Caraceni A., Zecca E., Martini C., De Conno F. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage. 17:1999;441-445.
6. Carrazana E.J., Schachter S.C. Alternative uses of lamotrigine and gabapentin in the treatment of trigeminal neuralgia. [letter; comment] Neurology. 50:1998;1192.
7. Conover W.J., Iman R.L. Analysis of covariance using the rank transformation. Biometrics. 38:1982;715-724.
8. Fleiss J.L. Statistical methods for rates and proportions. 2nd ed. 1981;Wiley, New York, NY.
9. Galer B.S., Jensen M.P. Development and preliminary validation of a pain measure specific to neuropathic pain. The neuropathic pain scale. Neurology. 48:1997;332-338.
10. Guerje O., Von Korff Simon G.E., Gater R. Persistent pain and well-being. A World Health Organization study in primary care. J Am Med Assoc. 280:1998;147-151.
11. Haythornthwaite J.A., Benrud-Larson L.M. Psychological aspects of neuropathic pain. Clin J Pain. 16:2000;S101-S105.
12. Houtchens M.K., Richert J.R., Sami A., Rose J.W. Open label gabapentin treatment for pain in multiple sclerosis. Multiple Sclerosis. 3:1997;250-253.
13. Karlsten R., Gordh T. How do drugs relieve neurogenic pain? Drugs Aging. 11:1997;398-412.
14. Khan O.A. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology. 51:1998;611-614.
15. McQuay H.J., Moore R.A. An evidence-based resource for pain relief. 1998;Oxford University Press, Oxford.
16. McQuay H., Carroll D., Jadad A.R., Wiffen P., Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ. 311:1995;1047-1052.
17. Mellick G.A., Mellick L.B. Reflex sympathetic dystrophy treated with gabapentin. Arch Phys Med Rehabil. 78:1997;98-105.
18. Mellick G.A., Mellicy L.B., Mellick L.B. Gabapentin in the management of reflex sympathetic dystrophy. [letter] J Pain Symptom Manage. 10:1995;265-266.
19. Merskey H., Bogduk N., Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. 1994;IASP Press, Seattle, WA.
20. Rice A.S.C., Maton S. Postherpetic neuralgia study group. Gabapentin in postherpetic neuralgia: a randomised double-blind placebo-controlled study. Pain. 94:2001;215-224.
21. Rosenberg J.M., Harrell C., Ristic H., Werner R.A., de Rosayro A.M. The effect of gabapentin on neuropathic pain. Clin J Pain. 13:1997;251-255.
22. Rowbotham M.C. What is a 'clinically meaningful' reduction in pain? Pain. 94:2001;131-132.
23. Rowbotham M.C., Fields H.L. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain. 119:1996;347-354.
24. Rowbotham M., Harden N., Stacey B., Bernstein P., Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. J Am Med Assoc. 280:1998;1837-1842.
25. Samkoff L.M., Daras M., Tuchman A.J., Koppel B.S. Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin. Neurology. 49:1997;304-305.
26. Serra J. Overview of neuropathic pain syndromes. Acta Neurol Scand Suppl. 173:1999;7-11.
27. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 83:1999;389-400.
28. Sist T., Filadora V., Miner M., Lema M. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology. 48:1997;1467.
29. Valzania F., Strafella A.P., Nassetti S.A., Tropeani A., Tassinari C.A. Gabapentin in idiopathic trigeminal neuralgia. Neurology. 50:(Suppl. 4):1998;. Abstract 379 P06.012.
30. Ware J.E.J. SF-36 Health Survey: manual and interpretation guide. 1993;The Health Institute, New England Medical Center, Boston, MA.
31. Wetzel C.H., Connelly J.F. Use of gabapentin in pain management. Ann Pharmacother. 31:1997;1082-1083.
32. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 353:1999;1959-1964.